SUCCIPRO S.L. a new spin-off from the Pere Virgili Institute for Health Research (IISPV-CERCA) and the Rovira Virgili University (URV) that will work on succinate modulating therapies to develop drugs aimed at helping patients with inflammatory and metabolic disorders
According to the World Health Organization (WHO), non-communicable diseases kill 41 million people every year. These include a wide range of metabolic diseases, such as obesity and its associated diseases (type 2 diabetes, fatty liver disease), and other diseases with a strong inflammatory component, such …